The challenge ahead lies in the identification of the BCR signaling events and characterization of B cell-specific TLR ligands in atherosclerosis with an explicit focus on B cell subsets that potentially might have a unique combinatory response to BCR and TLR engagements. The gene discussed is BCR; the disease is atherosclerosis.